Literature DB >> 1912923

'Brittle' diabetes.

G Williams, G V Gill, J C Pickup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1912923      PMCID： PMC1670919          DOI： 10.1136/bmj.303.6804.714

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  8 in total

1.  In vivo chloroquine-induced inhibition of insulin degradation in a diabetic patient with severe insulin resistance.

Authors:  B R Blazar; C B Whitley; A E Kitabchi; M Y Tsai; J Santiago; N White; F B Stentz; D M Brown
Journal:  Diabetes       Date:  1984-12       Impact factor: 9.461

2.  Insulin resistance caused by massive degradation of subcutaneous insulin.

Authors:  E P Paulsen; J W Courtney; W C Duckworth
Journal:  Diabetes       Date:  1979-07       Impact factor: 9.461

3.  The etiology of incapacitating, brittle diabetes.

Authors:  D S Schade; D A Drumm; W C Duckworth; R P Eaton
Journal:  Diabetes Care       Date:  1985 Jan-Feb       Impact factor: 19.112

4.  Continuous intravenous insulin infusion in the management of brittle diabetes: etiologic and therapeutic implications.

Authors:  G Williams; J C Pickup; H Keen
Journal:  Diabetes Care       Date:  1985 Jan-Feb       Impact factor: 19.112

5.  In search of the subcutaneous-insulin-resistance syndrome.

Authors:  D S Schade; W C Duckworth
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

6.  Massive insulin resistance apparently due to rapid clearance of circulating insulin.

Authors:  G Williams; J C Pickup; H Keen
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

7.  Apparent insulin resistance due to abnormal enzymatic insulin degradation: a new mechanism for insulin resistance.

Authors:  A McElduff; C J Eastman; S P Haynes; K M Bowen
Journal:  Aust N Z J Med       Date:  1980-02

8.  Evidence for insulin degradation by muscle and fat tissue in an insulin resistant diabetic patient.

Authors:  G F Maberly; G A Wait; J A Kilpatrick; E G Loten; K R Gain; R D Stewart; C J Eastman
Journal:  Diabetologia       Date:  1982-10       Impact factor: 10.122
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.